MetLife Investment Management’s Immunome IMNM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$394K	Hold	42,411	–	–	﹤0.01%	1797
2025 Q1	$285K	Buy	42,411 +6,792	+19%	+$45.7K	﹤0.01%	2000
2024 Q4	$378K	Buy	35,619 +5,354	+18%	+$56.9K	﹤0.01%	1952
2024 Q3	$442K	Buy	30,265 +17,053	+129%	+$249K	﹤0.01%	1844
2024 Q2	$160K	Buy	+13,212	New	+$160K	﹤0.01%	2378